Defective TGF-β signaling in bone marrow-derived cells prevents hedgehog-induced skin tumors

45Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Hedgehog signaling in cancer cells drives changes in the tumor microenvironment that are incompletely understood. Here, we report that hedgehog-driven tumors exhibit an increase in myeloid-derived suppressor cells (MDSC) and a decrease in T cells, indicative of an immunosuppressive tumor microenvironment. This change was associated with activated TGF-β signaling in several cell types in basal cell carcinomas. We determined that TGF-β signaling in bone marrow-derived cells, not keratinocytes, regulates MDSC and promotes tumor development. Tgfbr2 deficiency in the bone marrow-derived cells also reduced the size of previously developed tumors in mice. We identified CCL2 as the major chemokine attracting MDSCs to tumor, whose expression was Tgfbr2-dependent, whereas its receptor CCR2 was highly expressed in MDSC population. CCL2 alone was sufficient to induce migration of MDSCs. Moreover, the CCR2 inhibitors prevented MDSC migration toward skin cells in vitro, and reduced MDSC accumulation and hedgehog signaling-driven tumor development in mice. Our results reveal a signaling network critical for hedgehog signaling in cancer cells to establish an effective immunosuppressive microenvironment during tumor development. © 2013 American Association for Cancer Research.

Cite

CITATION STYLE

APA

Fan, Q., Gu, D., Liu, H., Yang, L., Zhang, X., Yoder, M. C., … Xie, J. (2014). Defective TGF-β signaling in bone marrow-derived cells prevents hedgehog-induced skin tumors. Cancer Research, 74(2), 471–483. https://doi.org/10.1158/0008-5472.CAN-13-2134-T

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free